Qian Bingnan, Li Xiaoqing, Wang Yu, Hou Junhua, Liu Jikui, Zou Sihao, An Fengchao, Lu Wenjun
Shenzhen Key Laboratory of Intelligent Robotics and Flexible Manufacturing Systems, Department of Mechanical and Energy Engineering, Southern University of Science and Technology, Shenzhen, 518055, China.
Department of Materials Science and Engineering, KTH Royal Institute of Technology, Stockholm, SE-10044, Sweden.
Adv Mater. 2024 Jun;36(24):e2310926. doi: 10.1002/adma.202310926. Epub 2024 Mar 14.
Biomedical alloys are paramount materials in biomedical applications, particularly in crafting biological artificial replacements. In traditional biomedical alloys, a significant challenge is simultaneously achieving an ultra-low Young's modulus, excellent biocompatibility, and acceptable ductility. A multi-component body-centered cubic (BCC) biomedical high-entropy alloy (Bio-HEA), which is composed of non-toxic elements, is noteworthy for its outstanding biocompatibility and compositional tuning capabilities. Nevertheless, the aforementioned challenges still remain. Here, a method to achieve a single phase with the lowest Young's modulus among the constituent phases by precisely tuning the stability of the BCC phase in the Bio-HEA, is proposed. The subtle tuning of the BCC phase stability also enables the induction of stress-induced martensite transformation with extremely low trigger stress. The transformation-induced plasticity and work hardening capacity are achieved via the stress-induced martensite transformation. Additionally, the hierarchical stress-induced martensite twin structure and crystalline-to-amorphous phase transformation provide robust toughening mechanisms in the Bio-HEA. The cytotoxicity test confirms that this Bio-HEA exhibits excellent biocompatibility without cytotoxicity. In conclusion, this study provides new insights into the development of biomedical alloys with a combination of ultra-low Young's modulus, excellent biocompatibility, and decent ductility.
生物医学合金是生物医学应用中的关键材料,尤其是在制造生物人工替代物方面。在传统生物医学合金中,一个重大挑战是同时实现超低杨氏模量、优异的生物相容性和可接受的延展性。一种由无毒元素组成的多组分体心立方(BCC)生物医学高熵合金(Bio-HEA),因其出色的生物相容性和成分调节能力而值得关注。然而,上述挑战仍然存在。在此,提出了一种通过精确调节Bio-HEA中BCC相的稳定性来在组成相中实现具有最低杨氏模量的单相的方法。对BCC相稳定性的微调还能够诱导触发应力极低的应力诱发马氏体转变。通过应力诱发马氏体转变实现了转变诱发塑性和加工硬化能力。此外,分级应力诱发马氏体孪晶结构和晶态到非晶态的相变在Bio-HEA中提供了强大的增韧机制。细胞毒性测试证实这种Bio-HEA表现出优异的生物相容性且无细胞毒性。总之,本研究为开发兼具超低杨氏模量、优异生物相容性和良好延展性的生物医学合金提供了新的见解。